期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Occult persistence and lymphotropism of hepatitis C virus infection 被引量:3
1
作者 Tram NQ Pham Tomasz I Michalak 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第18期2789-2793,共5页
Recent discovery of occult hepatitis C virus (HCV) infection persisting after spontaneous or antiviral therapy-induced resolution of hepatitis C was made possible by the introduction of nucleic acid amplification assa... Recent discovery of occult hepatitis C virus (HCV) infection persisting after spontaneous or antiviral therapy-induced resolution of hepatitis C was made possible by the introduction of nucleic acid amplification assays capable of detecting HCV RNA at sensitivities superseding those offered by clinical tests. Although individuals with this seemingly silent HCV infection are usually anti-HCV antibody reactive and have normal liver function tests, occult HCV infection has also been reported in anti-HCV-negative individuals with persistently elevated liver enzymes of unknown etiology. Studies have shown that HCV RNA can persist for years in serum, lymphomononuclear cells and liver in the absence of clinical symptoms, although histological evidence of a mild inflammatory liver injury can be occasionally encountered. Furthermore, while HCV RNA can be detected in circulating lymphoid cells in approximately 30% of cases, a short-term culture under stimulatory conditions augments HCV replication in these cells allowing detection of virus in otherwise HCV-negative cases. HCV infects different immune cell subsets, including CD4+ and CD8+ T lymphocytes, B cells and monocytes. Studies employing clonal sequencing and single-stranded conformational polymorphism analyses have revealed unique HCV variants residing in immune cells, further strengthening the notion of HCV lymphotropism. Overall, the data accumulated suggest that occult HCV infection is a common consequence of resolution of symptomatic hepatitis C and that examination of the cells of the immune system is an effective approach to diagnosis of HCV infection and its long-term persistence. Further work is required to fully realize pathogenic and epidemiological consequences of occult HCV persistence. 展开更多
关键词 Hepatitis C virus Chronic hepatitis C Occul tviral persistence HCV lymphotropism Consequences of occult HCV persistence
暂未订购
Establishment and validation of an LC-MS/MS method for detecting lipid metabolites in serum as biomarkers in colorectal cancer
2
作者 Xiaoying Lou Jia Li +6 位作者 Xudong Dai Kai Lin Xingting Guo Yiling Li Qingxia Xu Feng Chen Wei Cui 《Chinese Medical Journal》 2025年第24期3479-3481,共3页
To the Editor:The incidence and mortality of colorectal cancer(CRC)in China have increased significantly in recent years.Surpassing gastric cancer,CRC has become one of the main cancers threatening the life and health... To the Editor:The incidence and mortality of colorectal cancer(CRC)in China have increased significantly in recent years.Surpassing gastric cancer,CRC has become one of the main cancers threatening the life and health of Chinese people and causing a serious social burden.Early detection of CRC is critical for improving outcomes.Although colonoscopy remains the primary diagnostic and screening method,its invasiveness and low patient compliance hinder broad application.Non-invasive methods including fecal occult blood tests and carcinoembryonic antigen(CEA)lack sensitivity(20–40%)and specificity for early detection.Therefore,non-invasive biomarkers with high sensitivity and specificity for detecting CRC and precancerous adenomas are urgently needed.Altered gut microbiota is closely associated with colorectal carcinogenesis but exhibits high interindividual variability,limiting its clinical utility.Microbiota-derived metabolites such as bile acids and short-chain fatty acids are critical in CRC progression.Serum metabolite levels are strongly correlated with gut microbial abundance,providing a new direction for noninvasive diagnosis of CRC. 展开更多
关键词 lipid metabolites colorectal cancer gastric cancercrc non invasive diagnosis gut microbiota biomarkers fecal occul serum metabolites
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部